Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells.
- Author:
	        		
		        		
		        		
			        		Saleh ALTUWAIJRI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Cheng-Chia WU
			        		
			        		;
		        		
		        		
		        		
			        		Yuan-Jie NIU
			        		
			        		;
		        		
		        		
		        		
			        		Atsushi MIZOKAMI
			        		
			        		;
		        		
		        		
		        		
			        		Hong-Chiang CHANG
			        		
			        		;
		        		
		        		
		        		
			        		Chawnshang CHANG
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Cell Cycle; drug effects; Cell Line, Tumor; Cell Proliferation; DNA, Complementary; biosynthesis; Dihydrotestosterone; pharmacology; Humans; Male; Promoter Regions, Genetic; Prostatic Neoplasms; metabolism; pathology; Receptors, Androgen; biosynthesis; genetics; Transfection
 - From: Asian Journal of Andrology 2007;9(2):181-188
 - CountryChina
 - Language:English
 - 
		        	Abstract:
			       	
			       		
				        
				        	
AIMTo examine the physiological role of the androgen receptor (AR) in the PC-3 cell line by transfecting full-length functional AR cDNA driven by its natural human AR promoter.
METHODSWe generated an AR-expressing PC-3(AR)9 stable clone that expresses AR under the control of the natural human AR promoter and compared its proliferation to that of the PC-3(AR)2 (stable clone that expresses AR under the control of the cytomegalovirus (CMV) promoter, established by Heisler et al.) after androgen treatment.
RESULTSWe found that dihydrotestosterone (DHT) from 0.001 nmol/L to 10 nmol/L induces cell cycle arrest or inhibits proliferation of PC-3(AR)2 compared with its vector control, PC-3(pIRES). In contrast, PC-3(AR)9 cell growth slightly increased or did not change when treated with physiological concentrations of 1 nmol/L DHT.
CONCLUSIONThese data suggest that intracellular control of AR expression levels through the natural AR promoter might be needed for determining AR function in androgen-independent prostate cancer (AIPC) PC-3 cells. Unlike previous publications that showed DHT mediated suppression of PC-3 growth after transfection of viral promoter-driven AR overexpression, we report here that DHT-mediated PC-3 proliferation is slightly induced or does not change compared with its baseline after reintroducing AR expression driven by its own natural promoter, as shown in PC-3(AR)9 prostate cancer cells.
 
            